Guide

Esketamine (Spravato), explained simply

Reviewed by the editorial team · Written in plain language for St. Charles County readers

If your doctor mentioned esketamine, or you saw the brand name Spravato online, you probably have questions. It sounds unfamiliar and a little intimidating. The reality is more ordinary than it sounds. Here is a straightforward explanation, without the hype and without the fear.

What it actually is

Esketamine is a prescription nasal spray. It is closely related to ketamine, a medicine that has been used safely in hospitals for decades. In 2019 the U.S. Food and Drug Administration approved esketamine, under the brand name Spravato, for adults with treatment-resistant depression - meaning depression that has not improved after trying other antidepressants. It is also approved to help adults with major depression who are having suicidal thoughts.

What makes it notable is how it works. Most antidepressants act slowly on brain chemicals like serotonin over weeks. Esketamine works through a different pathway in the brain, and some people notice a shift in mood faster than they would with a traditional pill. It is not a cure, and it does not work for everyone, but for people who felt out of options it opened a new door.

How it is given

This is the part that surprises people. Esketamine is not something you pick up and use at home whenever you like. Because of how it affects you, it is given in a certified medical setting under supervision. A typical visit looks like this:

• You take the nasal spray yourself, in the clinic, with staff present.
• You stay and are monitored for about two hours afterward.
• Because it can make you feel drowsy or temporarily off-balance, you arrange a ride home and do not drive for the rest of the day.
• Early on, visits are usually twice a week, then taper down over time based on how you respond.

This structure is a safety feature, not a red flag. The supervision is exactly what makes it a controlled, medically responsible treatment.

Who it is - and isn't - for

Esketamine is meant for adults whose depression has not responded to other treatments. It is not a first step, and it is not for mild, short-term low mood. Your provider will review your history, other medications, and health conditions to decide whether it is appropriate. Certain conditions, such as some blood-pressure or vascular problems, may make it a poor fit. Honest screening is part of good care.

Common side effects

The most common effects happen during or shortly after a session and tend to fade before you leave: a floaty or dissociated feeling, mild dizziness, nausea, or a temporary rise in blood pressure. That is one more reason for the in-clinic monitoring. Serious problems are uncommon when it is given properly, but you should always report anything that worries you.

Is it covered by insurance?

Because esketamine is FDA-approved for treatment-resistant depression, many insurance plans cover it, though they often require documentation that other treatments were tried first. In Missouri, coverage can include MO HealthNet through providers who accept it. The clearest way to find out is to ask a clinic that offers the treatment to check your specific plan.

Esketamine is not a miracle and it is not a shortcut. It is one more real, evidence-based option for people who have been let down by the usual path. If that is you, it is worth an honest conversation with a qualified provider.